DekaBank Deutsche Girozentrale’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80,000
Closed -$916K 1368
2022
Q3
$916K Buy
80,000
+63,700
+391% +$791K ﹤0.01% 892
2022
Q2
$129K Hold
16,300
﹤0.01% 1262
2022
Q1
$145K Buy
16,300
+1,500
+10% +$14.5K ﹤0.01% 1246
2021
Q4
$157K Buy
14,800
+400
+3% +$4.75K ﹤0.01% 1301
2021
Q3
$189K Hold
14,400
﹤0.01% 1219
2021
Q2
$119K Hold
14,400
﹤0.01% 1308
2021
Q1
$123K Hold
14,400
﹤0.01% 1263
2020
Q4
$137K Hold
14,400
﹤0.01% 1235
2020
Q3
$181K Buy
+14,400
New +$191K ﹤0.01% 1064

Other funds holding GOSS

DekaBank Deutsche Girozentrale's GOSS Position: Q4 2022 in Review

DekaBank Deutsche Girozentrale sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 80,000 shares — an estimated $916K sold.

DekaBank Deutsche Girozentrale first reported a position in GOSS in Q3 2020 and held it in 9 quarters. The position peaked at $916K in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 80,000 Gossamer Bio shares in Q4 2022, an estimated $916K.
  • DekaBank Deutsche Girozentrale first reported a position in Gossamer Bio in Q3 2020 and held it in 9 quarters.
  • DekaBank Deutsche Girozentrale's Gossamer Bio position peaked at $916K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.